HMNC Holding GmbH

HMNC Brain Health defines the future of depression and anxiety therapy: We develop innovative personalized therapies with the aim of shortening the duration of treatment, improving therapy outcomes and reducing the risk of relapse. The core activities of our company are the preclinical and clinical development and commercialization of innovative drugs for depression and anxiety disorders as well as laboratory tests that help to better target antidepressants on the market.